Phase 3 Data for Incyte's Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

6 months ago 23
Read Entire Article
  1. Homepage
  2. Finance
  3. Phase 3 Data for Incyte's Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

Related

China says it hopes firms seek lawful, balanced solutions over TikTok deal

China says it hopes firms seek lawful, balanced solutions ov...

3 minutes ago 1
China accuses US of distorting its defence policy in relation to India ties

China accuses US of distorting its defence policy in relatio...

3 minutes ago 1
Japan stocks higher at close of trade; Nikkei 225 up 0.08%

Japan stocks higher at close of trade; Nikkei 225 up 0.08%

1 hour ago 1

Trending

1. chinese new year 2026
2. san francisco weather
3. robert kennedy jr
4. clavicular runs over person
5. rfk jr
6. laredo solti
7. usha vance
8. lululemon
9. true detective
10. kourtney kardashian

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 645
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 512
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 377
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 334
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 329
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved